




Searching News Database: Fresenius Kabi
HSMN NewsFeed - 7 Aug 2023
Ligandal Inc. Appoints Tushar Nuwal as Chief Operating Officer and Chief Business Officer
Ligandal Inc. Appoints Tushar Nuwal as Chief Operating Officer and Chief Business Officer
HSMN NewsFeed - 18 Oct 2018
AbbVie Announces Global Resolution of HUMIRA(R) (adalimumab) Patent Disputes with Fresenius Kabi
AbbVie Announces Global Resolution of HUMIRA(R) (adalimumab) Patent Disputes with Fresenius Kabi
HSMN NewsFeed - 7 Oct 2016
Fresenius Kabi Receives FDA 510(k) Clearance for the Aurora(TM) Xi Plasmapheresis System
Fresenius Kabi Receives FDA 510(k) Clearance for the Aurora(TM) Xi Plasmapheresis System
HSMN NewsFeed - 25 Feb 2016
Sagent Pharmaceuticals Names Frank Harmon Executive Vice President Global Operations
Sagent Pharmaceuticals Names Frank Harmon Executive Vice President Global Operations
HSMN NewsFeed - 11 Nov 2013
InnoPharma Inc. Appoints Vish Shetty as Vice President, Business Development & Alliance Management
InnoPharma Inc. Appoints Vish Shetty as Vice President, Business Development & Alliance Management
HSMN NewsFeed - 22 May 2012
MagForce signs distribution agreement with leading Russian medical device distribution company DELRUS
MagForce signs distribution agreement with leading Russian medical device distribution company DELRUS
HSMN NewsFeed - 26 Mar 2011
APP Pharmaceuticals Issues a Nationwide Voluntary Recall of Irinotecan Hydrochloride Injection
APP Pharmaceuticals Issues a Nationwide Voluntary Recall of Irinotecan Hydrochloride Injection
HSMN NewsFeed - 30 Oct 2010
APP Pharmaceuticals Announces Approval of Metoprolol Tartrate Injection, USP
APP Pharmaceuticals Announces Approval of Metoprolol Tartrate Injection, USP
HSMN NewsFeed - 21 Jun 2010
APP Pharmaceuticals Announces Approval and Launch of First Generic Aztreonam for Injection, USP
APP Pharmaceuticals Announces Approval and Launch of First Generic Aztreonam for Injection, USP
HSMN NewsFeed - 2 Dec 2009
Thomas H. Silberg to Retire as President and CEO of APP Pharmaceuticals, John Ducker Named as Successor
Thomas H. Silberg to Retire as President and CEO of APP Pharmaceuticals, John Ducker Named as Successor
HSMN NewsFeed - 25 Aug 2009
APP Pharmaceuticals Receives Approval for Penicillin G Potassium for Injection, USP
APP Pharmaceuticals Receives Approval for Penicillin G Potassium for Injection, USP
HSMN NewsFeed - 2 Sep 2008
APP Pharmaceuticals and Fresenius Announce Clearance of APP Acquisition by U.S. Federal Trade Commission
APP Pharmaceuticals and Fresenius Announce Clearance of APP Acquisition by U.S. Federal Trade Commission
Additional items found! 4

Members Archive contains
4 additional stories matching:
Fresenius Kabi
(Password required)
Fresenius Kabi
(Password required)